SIGA Technologies Inc. (SIGA) financial statements (2021 and earlier)

Company profile

Business Address 31 EAST 62ND STREET
NEW YORK, NY 10065
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1187953776578100
Cash and cash equivalents1187953776578100
Restricted cash and investments    961111
Receivables340372434
Inventory, net of allowances, customer advances and progress billings201114161042
Inventory201114161042
Other undisclosed current assets2113524
Total current assets:1441311059818099122
Noncurrent Assets
Property, plant and equipment2223333
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Restricted cash and investments361116 8764
Other noncurrent assets1111111
Deferred tax assets, net12
Other undisclosed noncurrent assets    1413 
Total noncurrent assets:61015211910482
TOTAL ASSETS:150141120119199203203
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10161621121211
Accounts payable1115321
Accrued liabilities915151791010
Debt    80  
Total current liabilities:10161621921211
Noncurrent Liabilities
Other undisclosed noncurrent liabilities101211998889
Total noncurrent liabilities:101211998889
Total liabilities:20282630101100100
Stockholders' equity
Stockholders' equity attributable to parent130113948898103103
Common stock0000000
Additional paid in capital225222221221221221221
Accumulated deficit(95)(109)(127)(133)(123)(119)(117)
Total stockholders' equity:130113948898103103
TOTAL LIABILITIES AND EQUITY:150141120119199203203

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues3844403484
Cost of revenue(5)(6)(5)(0)(0)(1) 
Cost of goods and services sold(4)(6)(5)(0)   
Gross profit:3339352474
Operating expenses(6)(6)(7)(6)(8)(7)(6)
Other undisclosed operating income    01 
Operating income (loss):273329(4)(3)1(2)
Nonoperating income0000111
Interest and debt expense   (8)(4)(4)(4)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(1)(1)(2)(0)011
Income (loss) from continuing operations before income taxes:263227(12)(6)(2)(4)
Income tax expense (benefit)(6)(7)(6)3201
Net income (loss) available to common stockholders, diluted:202421(9)(5)(1)(3)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):202421(9)(5)(1)(3)
Comprehensive income (loss), net of tax, attributable to parent:202421(9)(5)(1)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: